| Title |
Value |
| Polysaccharide |
FCSPs |
| Source Name |
Sargassum fusiforme |
| Weight |
|
| Main Glycosidic Bond(s) |
| β-Xylp-(1→4) |
| β-Galp-(1→4) |
|
| Main Chain |
the type I polysaccharides were composed of a linear backbone formed mainly by (1→6)-β-D-galactose and (1→2)-β-D-mannose with branching chains formed by (1→3) and (1→4)-α-L-fucose、 (1→4)-α-D-glucuronic acid |
| Side Chain |
The type I polysaccharides had branching chains formed by (1→3) and/or (1→4)-α-L-fucose, (1→4)-α-D-glucuronic acid, while in the type II polysaccharides the backbone was mainly built of short galactan chains. |
| NMR Information |
yes
|
| Monosaccharide |
| glucose |
10.0% |
| mannose |
15.0% |
| galactose |
25.0% |
| xylose |
20.0% |
| fucose |
30.0% |
|
| Physiological Functions |
anti-oxidant
anti-tumour
immunoregulation
anti-coagulation
抗炎
|
| Intestinal Microbiota Regulation |
unknown
|
| Related Diseases (based on ICD-11) |
Malignant neoplasms,04-Diseases of the immune system |
| Correlation map |
Click to view |
| DOI |
10.3390/md9102106 |
Data Source Statement:
The data included in the DoLPHiN database is sourced exclusively from peer-reviewed original publications and presented after normalization.
